Pharmacokinetic-Pharmacodynamic Modelling of Danofloxacin in Turkeys
✍ Scribed by A. M. Haritova; N. V. Rusenova; P. R. Parvanov; L. D. Lashev; J. Fink-Gremmels
- Publisher
- Springer Netherlands
- Year
- 2006
- Tongue
- English
- Weight
- 201 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0165-7380
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The use of the angiotensin converting enzyme inhibitor, captopril, specially in children, has been empirical. This is because the relationship between the pharmacokinetics and pharmacodynamics of captopril has not been clearly defined. It is not usually feasible to obtain the serial kinetic-dynamic
The plasma pharmacokinetics of danofloxacin administered at 1.25 mg kg -1 body weight by the intravenous and intramuscular routes were determined in sheep. Tissue distribution was also determined following administration by the intramuscular route at 1.25 mg kg -1 body weight. Danofloxacin had a lar